Alere™ i Strep A provides lab-accurate, molecular results in 8 minutes or less on the user-friendly Alere™i platform. Alere™ i Strep A can be used with ease and confidence in the laboratory, emergency department, pediatrics or physician’s office; allowing you to treat accurately during the patient’s visit. Alere™ i Strep A is now CLIA-waived.

Alere™ i Strep A:

• Early call for positive results
• Gives you confidence to make appropriate clinical decisions sooner
• Allows for the accurate detection of Group A Strep
• Increased detection compared to culture1
• Molecular sensitivity in an actionable timeframe allows the prudent use of antibiotics

Outstanding Performance

Alere™ i Strep A Performance vs. Culture

a. Of the 6 samples negative by Alere™ i Strep A and positive by bacterial culture, 4 samples were also negative for Group A Strep by a laboratory developed real-time PCR assay.
b. Of the 18 samples positive by Alere™ i Strep A and negative by bacterial culture, 13 were also positive for Group A Strep by a laboratory developed real-time PCR assay.

Faster Results

Alere™ i Strep A is significantly faster than other molecular methods and more accurate than conventional rapid testing, giving you the confidence to make effective patient management decisions sooner.

The Alere™ i Strep A kit contains all components required to carry out an assay for Strep A on the Alere™ i instrument. It tests for the qualitative detection of Streptococcus pyogenes from bacterial nucleic acid in throat swab specimens.

For more detail: https://www.news-medical.net/ads/abmc.aspx?b=1961